Type 2 Diabetes: Causes, Insulin Resistance, and Blood Sugar Management

A Metabolic System That Has Broken Down

More than 37 million Americans have diabetes, and approximately 90 to 95 percent of them have type 2 — making it one of the most prevalent chronic diseases in the United States. Globally, the International Diabetes Federation estimates that 537 million adults lived with diabetes in 2021, a number projected to reach 783 million by 2045. Type 2 diabetes develops when the body can no longer maintain normal blood glucose levels because cells have become resistant to insulin and the pancreas can no longer compensate with sufficient insulin production.

Unlike type 1 diabetes, which results from autoimmune destruction of insulin-producing beta cells, type 2 is characterized by a gradual metabolic dysfunction that develops over years or decades. Early intervention can halt or reverse its progression.

The Physiology of Insulin Resistance

Insulin is a hormone produced by beta cells in the pancreas. Its function is to signal cells — particularly muscle, fat, and liver cells — to absorb glucose from the bloodstream. In a healthy system, blood glucose rises after eating, the pancreas releases insulin, cells absorb glucose, and blood sugar returns to baseline.

Insulin resistance disrupts this process. Cells become less responsive to insulin's signal, requiring increasingly large amounts of insulin to achieve the same effect. The pancreas compensates by producing more insulin. For years or decades, this compensatory hyperinsulinemia keeps blood glucose in a normal range — but at great metabolic cost. Beta cells are under constant pressure.

Eventually, beta cell function begins to decline. The pancreas can no longer produce enough insulin to overcome the resistance. Blood glucose rises. The threshold for type 2 diabetes has been crossed.

Risk Factors and Their Biological Mechanisms

• Obesity and abdominal fat: Visceral fat tissue is metabolically active, releasing free fatty acids and inflammatory cytokines (including TNF-alpha and IL-6) that impair insulin signaling in muscle and liver cells
• Physical inactivity: Skeletal muscle is the primary site of insulin-stimulated glucose uptake; inactivity reduces GLUT4 transporter expression in muscle cells
• Genetics: Heritability is estimated at 30 to 70 percent; over 400 genetic loci have been associated with type 2 diabetes risk
• Age: Beta cell function and insulin sensitivity both decline with age; risk increases substantially after age 45
• Ethnicity: African American, Hispanic, Native American, and Asian American populations have higher type 2 diabetes prevalence than non-Hispanic white populations at the same BMI
• Gestational diabetes history: Women who developed gestational diabetes have a 7-fold increased risk of developing type 2 diabetes later in life

Diagnostic Criteria

The American Diabetes Association (ADA) defines type 2 diabetes using four criteria, any one of which (confirmed on a repeat test unless symptoms are unequivocal) establishes the diagnosis:

(OGTT = oral glucose tolerance test. A1C reflects average blood glucose over the preceding 2–3 months.)

An estimated 96 million American adults have prediabetes — elevated blood glucose that has not yet reached the diabetic threshold. Without intervention, 15 to 30 percent of people with prediabetes will develop type 2 diabetes within 5 years.

Complications of Uncontrolled Type 2 Diabetes

Chronic hyperglycemia damages blood vessels and nerves throughout the body. The major complications are:

• Cardiovascular disease: Diabetes doubles the risk of heart disease and stroke; cardiovascular disease is the leading cause of death in people with type 2 diabetes
• Diabetic nephropathy: Damages the kidney's filtration system; the leading cause of end-stage renal disease (ESRD) in the U.S.
• Diabetic retinopathy: Damages retinal blood vessels; the leading cause of new blindness in working-age adults
• Peripheral neuropathy: Damages nerves in the feet and hands, causing pain, numbness, and loss of protective sensation; leads to lower-limb amputations
• Diabetic foot disease: Non-healing ulcers from neuropathy and vascular insufficiency; approximately 100,000 diabetes-related amputations occur annually in the U.S.

Treatment Approaches

Remission and Prevention

Type 2 diabetes is not irreversible in its early stages. Substantial weight loss — typically 15 percent or more of body weight — can restore normal blood glucose levels without medication in some individuals. The DiRECT trial (2018) demonstrated that a structured dietary intervention achieving mean weight loss of 10 kg induced remission in 46 percent of participants at one year.

The Diabetes Prevention Program (DPP), a landmark NIH-funded trial, showed that intensive lifestyle intervention reducing body weight by 7 percent and increasing physical activity to 150 minutes per week cut the risk of progression from prediabetes to type 2 diabetes by 58 percent — outperforming metformin (31 percent reduction) in participants over 60.

This article is for informational purposes only. Consult a qualified healthcare professional before making any health decisions.